iDtheinvestordatabase
Home / Directory / Star51 Capital
Active: new deal Sep 2026 Verified 4 Nov 2026

Star51 Capital

Investor in the convergence of medtech and AI, backing founders and management teams from early through growth stage, with a first close led by Abbott and Mayo Clinic. Based in New York, NY.

Type
VC firm
Location
New York, New York, United States
Stages
Seed, Series A, Series B, Growth
Backs
Medtech and digital health, Biotech and pharma
Sectors
Healthtech and life sciences, AI, Robotics, Media
Fund size / AUM
Fund size not disclosed on Form D
Latest fund or filing
9 Jun 2026
Portfolio mix
Medtech and digital health 65%; Biotech and pharma 18%; B2B software 12%; Hardware 6% (n=17)

Fund filings (SEC Form D)

Latest fund on file
Star51 Capital Fund I
Filed
9 Jun 2026 (new notice)
Fund size
Not disclosed on the filing
Fund vehicles filed in the last 12 months
1 (includes feeder and parallel vehicles)

See this fund's filings on SEC EDGAR

Contacts on file

For Star51 Capital, the paid file holds: 3 named decision-makers with roles; firm contact email (domain checked).

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

UltraSightApreoAxonVitVioLeo Cancer Care

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 82 lists

Series B media investors in the US (16)Robotics investors in New York (17)Media investors in New York (20)Series B robotics investors in the US (20)Growth-stage robotics investors in the US (20)Growth-stage media investors in the US (22)Series B media investors (24)Series B robotics investors (26)Series B investors in New York (29)Biotech investors in New York (29)Growth-stage robotics investors (31)Series B biotech investors in the US (34)Series B medtech investors in the US (36)Series A media investors in the US (36)Growth-stage biotech investors in the US (44)Series A robotics investors in the US (44)Growth-stage media investors (45)Series A investors in New York (49)Medtech investors in New York (53)Growth-stage investors in New York (57)Series B medtech investors (57)Series A media investors (59)Series A biotech investors in the US (59)Series A robotics investors (64)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Series B biotech investors (73)Series A medtech investors in the US (76)Seed media investors in the US (81)Healthtech investors in New York (100)Growth-stage medtech investors (107)Growth-stage biotech investors (109)Seed robotics investors in the US (120)Growth-stage healthtech investors in the US (121)Series A medtech investors (125)Seed media investors (125)Series B AI investors in the US (126)Seed investors in New York (128)Media venture capital firms in the US (135)Series A biotech investors (153)Seed robotics investors (153)AI investors in New York (159)Seed biotech investors in the US (159)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)Robotics venture capital firms in the US (179)Media investors (200)Series B AI investors (204)Seed medtech investors in the US (205)Robotics investors (217)Emerging VC managers in the US (274)Seed medtech investors (278)Series A AI investors in the US (280)Growth-stage investors in the US (288)Growth-stage AI investors (295)Biotech venture capital firms in the US (297)Seed biotech investors (300)Growth-stage healthtech investors (316)Series B investors (339)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Seed healthtech investors in the US (437)Venture capital firms in New York (440)Medtech investors (457)Biotech investors (484)Series A AI investors (500)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Seed healthtech investors (800)Series A investors (864)Seed investors in the US (1,043)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)Active venture capital firms in the US (1,574)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)